JP Morgan Chase’s HUTCHMED HCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.12K | Hold |
638
| – | – | ﹤0.01% | 6767 |
|
|
2025
Q4 | $8.51K | Buy |
638
+598
| +1,495% | +$8.74K | ﹤0.01% | 6709 |
|
|
2025
Q3 | $630 | Hold |
40
| – | – | ﹤0.01% | 7033 |
|
|
2025
Q2 | $602 | Hold |
40
| – | – | ﹤0.01% | 6682 |
|
|
2025
Q1 | $602 | Sell |
40
-200
| -83% | -$2.96K | ﹤0.01% | 6683 |
|
|
2024
Q4 | $3.46K | Buy |
240
+191
| +390% | +$3.41K | ﹤0.01% | 6571 |
|
|
2024
Q3 | $957 | Sell |
49
-269
| -85% | -$4.86K | ﹤0.01% | 6730 |
|
|
2024
Q2 | $5.44K | Sell |
318
-3,491
| -92% | -$64.4K | ﹤0.01% | 6371 |
|
|
2024
Q1 | $64K | Buy |
3,809
+1,472
| +63% | +$22.3K | ﹤0.01% | 5846 |
|
|
2023
Q4 | $42.3K | Buy |
2,337
+3
| +0.1% | +$55 | ﹤0.01% | 6050 |
|
|
2023
Q3 | $39.5K | Sell |
2,334
-6,374
| -73% | -$91.3K | ﹤0.01% | 5868 |
|
|
2023
Q2 | $104K | Sell |
8,708
-8,791
| -50% | -$120K | ﹤0.01% | 5434 |
|
|
2023
Q1 | $228K | Sell |
17,499
-5,503
| -24% | -$90.2K | ﹤0.01% | 4987 |
|
|
2022
Q4 | $340K | Sell |
23,002
-235,703
| -91% | -$2.58M | ﹤0.01% | 4751 |
|
|
2022
Q3 | $2.29M | Sell |
258,705
-25,624
| -9% | -$322K | ﹤0.01% | 3361 |
|
|
2022
Q2 | $3.59M | Sell |
284,329
-129,120
| -31% | -$1.64M | ﹤0.01% | 3070 |
|
|
2022
Q1 | $7.82M | Sell |
413,449
-1,096,384
| -73% | -$27.9M | ﹤0.01% | 2617 |
|
|
2021
Q4 | $53M | Sell |
1,509,833
-162,945
| -10% | -$5.3M | 0.01% | 1182 |
|
|
2021
Q3 | $61.2M | Sell |
1,672,778
-550,159
| -25% | -$21.6M | 0.01% | 1076 |
|
|
2021
Q2 | $87.3M | Sell |
2,222,937
-1,129
| -0.1% | -$32.6K | 0.01% | 962 |
|
|
2021
Q1 | $62.8M | Buy |
2,224,066
+737,837
| +50% | +$23.5M | 0.01% | 1063 |
|
|
2020
Q4 | $47.6M | Buy |
1,486,229
+64,675
| +5% | +$1.99M | 0.01% | 1100 |
|
|
2020
Q3 | $45.1M | Buy |
1,421,554
+103,722
| +8% | +$3.23M | 0.01% | 1026 |
|
|
2020
Q2 | $36.3M | Buy |
1,317,832
+170,565
| +15% | +$3.7M | 0.01% | 1024 |
|
|
2020
Q1 | $20.5M | Buy |
1,147,267
+272,162
| +31% | +$6.56M | ﹤0.01% | 1242 |
|
|
2019
Q4 | $21.9M | Buy |
875,105
+51,805
| +6% | +$1.13M | ﹤0.01% | 1515 |
|
|
2019
Q3 | $14.7M | Buy |
823,300
+293,914
| +56% | +$6.12M | ﹤0.01% | 1827 |
|
|
2019
Q2 | $16M | Sell |
529,386
-134,229
| -20% | -$3.83M | ﹤0.01% | 1731 |
|
|
2019
Q1 | $20.3M | Buy |
663,615
+56,288
| +9% | +$1.4M | ﹤0.01% | 1523 |
|
|
2018
Q4 | $14M | Sell |
607,327
-680,746
| -53% | -$21.2M | ﹤0.01% | 1754 |
|
|
2018
Q3 | $41.5M | Sell |
1,288,073
-297,650
| -19% | -$9.07M | 0.01% | 1121 |
|
|
2018
Q2 | $47.8M | Buy |
1,585,723
+57,981
| +4% | +$1.84M | 0.01% | 995 |
|
|
2018
Q1 | $45.2M | Buy |
1,527,742
+274,658
| +22% | +$9.77M | 0.01% | 995 |
|
|
2017
Q4 | $49.4M | Buy |
1,253,084
+848,088
| +209% | +$27.1M | 0.01% | 991 |
|
|
2017
Q3 | $11M | Buy |
404,996
+186,170
| +85% | +$4.57M | ﹤0.01% | 1911 |
|
|
2017
Q2 | $5.1M | Buy |
+218,826
| New | +$4.49M | ﹤0.01% | 2458 |
|
Other funds holding HCM
AG
MGP
CGH
JP Morgan Chase's HCM Position: Q1 2026 in Review
JP Morgan Chase held its HUTCHMED (HCM) position steady in Q1 2026 at 638 shares worth $9.12K. The position accounts for ﹤0.01% of the portfolio, ranked #6767.
JP Morgan Chase first reported a position in HCM in Q2 2017 and has held it in 36 quarters since. The position peaked at $87.3M in Q2 2021. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.
- JP Morgan Chase held 638 shares of HUTCHMED worth $9.12K as of Q1 2026.
- JP Morgan Chase left its HUTCHMED share count unchanged in Q1 2026.
- HUTCHMED made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6767 holding.
- JP Morgan Chase first reported a position in HUTCHMED in Q2 2017 and has held it in 36 quarters since.
- JP Morgan Chase's HUTCHMED position peaked at $87.3M in Q2 2021.
- 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.